{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"hyperlipoproteinemia-type-v","columns":[{"gene":"","key":"population-60c454cc856778ab07cf","label":"Hyperlipoproteinemia, type V","mondoId":"MONDO:0007762","onsetQualifier":null,"originColumnKey":"MONDO:0007762/OMIM:144650","originalViews":[{"key":"MONDO:0007762/OMIM:144650","label":"Hyperlipoproteinemia, type V","scopeLabel":"OMIM:144650","sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"recordKeys":["023c852c1558f8170f2974de0bcfaf216005aa79fc666bb9a0845a7f83f680dc","13e510abdc8a9d8063ae6b0934e35e1557e895da315fb4de371317c44a80ff4e","17c31707ebbe16434cb10f5eec8d234746334ad7052ec15f18352b0394742e51","c682b4f1cdfcd33841162c93039c2a4c9e6bf01a740666dc2608b98a9fadda5d","f6e9aa71e3e41abfb850a6c7a7d97673877556215fda4156ccf27463c0ff7bd9"],"recordQualifiers":{},"scopeLabel":"OMIM:144650","sourceIds":["OMIM:144650"],"sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":["population-60c454cc856778ab07cf"],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":["HP:0003233","HP:0003563","HP:0000819","HP:0003362","HP:0012238"],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":0,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":5,"sourceGroups":{"omim":5}},"features":[{"hpoId":"HP:0003233","label":"Decreased circulating HDL-C concentration","primary":true},{"hpoId":"HP:0003563","label":"Decreased circulating LDL-C concentration","primary":true},{"hpoId":"HP:0000819","label":"Diabetes mellitus","primary":true},{"hpoId":"HP:0003362","label":"Elevated circulating VLDL-C concentration","primary":true},{"hpoId":"HP:0012238","label":"Increased circulating chylomicron concentration","primary":true}],"ledeHtml":"A severe type of hyperlipidemia, sometimes familial, that is characterized by the elevation of both plasma chylomicrons and triglycerides contained in very-low-density lipoproteins. Type V hyperlipoproteinemia is often associated with diabetes mellitus and is not caused by reduced lipoprotein lipase activity as in hyperlipoproteinemia type I.","mondoId":"MONDO:0007762","node":{"canonicalSlug":"hyperlipoproteinemia-type-v","comparisons":[{"documentSha256":"d86466f0224efb1c95cf1b1dfa8967165fbee306d7bb9bbdb5e5ea043a41865d","key":"legacy-hyperlipoproteinemia-type-v","kind":"legacy","label":"hyperlipoproteinemia type V","memberIds":["MONDO:0007762"],"mondoId":"MONDO:0007762","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/hyperlipoproteinemia-type-v.d86466f0224efb1c95cf1b1dfa8967165fbee306d7bb9bbdb5e5ea043a41865d.json"}],"contexts":[],"lifecycle":"active","narrative":{"causes":[],"contentForm":"definition-only","matchMethod":"same-ontology-node","name":"hyperlipoproteinemia type V","paragraphs":["A severe type of hyperlipidemia, sometimes familial, that is characterized by the elevation of both plasma chylomicrons and triglycerides contained in very-low-density lipoproteins. Type V hyperlipoproteinemia is often associated with diabetes mellitus and is not caused by reduced lipoprotein lipase activity as in hyperlipoproteinemia type I."],"scope":"exact","source":"MONDO","upstream":"MESH:D006954","url":"https://monarchinitiative.org/MONDO:0007762"},"ownColumnKeys":["population-60c454cc856778ab07cf"],"publication":"published","relationships":[{"kind":"parent","label":"familial hyperlipidemia","mondoId":"MONDO:0001336","slug":"familial-hyperlipidemia"}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[{"reason":"Name scope not exact or reviewed; Description attribution is outside exact node scope","source":"GARD","url":"https://rarediseases.info.nih.gov/diseases/6704"}],"translation":"pending"},"records":[{"frequencyKind":"reported","key":"023c852c1558f8170f2974de0bcfaf216005aa79fc666bb9a0845a7f83f680dc","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:144650","disease_name":"Hyperlipoproteinemia, type V","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0003233","is_excluded":false,"label":"Decreased circulating HDL-C concentration","onset_id":null,"reference":"OMIM:144650","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"13e510abdc8a9d8063ae6b0934e35e1557e895da315fb4de371317c44a80ff4e","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:144650","disease_name":"Hyperlipoproteinemia, type V","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0003362","is_excluded":false,"label":"Elevated circulating VLDL-C concentration","onset_id":null,"reference":"OMIM:144650","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"17c31707ebbe16434cb10f5eec8d234746334ad7052ec15f18352b0394742e51","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:144650","disease_name":"Hyperlipoproteinemia, type V","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0012238","is_excluded":false,"label":"Increased circulating chylomicron concentration","onset_id":null,"reference":"OMIM:144650","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"c682b4f1cdfcd33841162c93039c2a4c9e6bf01a740666dc2608b98a9fadda5d","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:144650","disease_name":"Hyperlipoproteinemia, type V","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0003563","is_excluded":false,"label":"Decreased circulating LDL-C concentration","onset_id":null,"reference":"OMIM:144650","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"f6e9aa71e3e41abfb850a6c7a7d97673877556215fda4156ccf27463c0ff7bd9","raw":{"aspect":"P","body_system":"endocrine","disease_id":"OMIM:144650","disease_name":"Hyperlipoproteinemia, type V","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0000819","is_excluded":false,"label":"Diabetes mellitus","onset_id":null,"reference":"OMIM:144650","source_release":"2026-06-23"},"sourceGroups":["omim"]}],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0007762\" rel=\"noreferrer\">MONDO</a></p><details class=\"deep-dive\"><summary>Narrative source and scope</summary><dl><dt>Content</dt><dd>definition-only</dd><dt>Scope</dt><dd>exact</dd><dt>Match method</dt><dd>same-ontology-node</dd><dt>Upstream attribution</dt><dd>MESH:D006954</dd></dl></details>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>A severe type of hyperlipidemia, sometimes familial, that is characterized by the elevation of both plasma chylomicrons and triglycerides contained in very-low-density lipoproteins. Type V hyperlipoproteinemia is often associated with diabetes mellitus and is not caused by reduced lipoprotein lipase activity as in hyperlipoproteinemia type I.</p><p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0007762\" rel=\"noreferrer\">MONDO</a></p>","key":"overview","title":"Brief description"}],"sharedSources":[],"slug":"hyperlipoproteinemia-type-v","sourceDocuments":[{"name":"MONDO: hyperlipoproteinemia type V","reviewed":null,"source_release":"releases/2026-10-06","url":"https://monarchinitiative.org/MONDO:0007762"}],"sourceNote":"","synonyms":["familial APOA5 deficiency","familial apolipoprotein A-V deficiency","familial apolipoprotein A5 deficiency","HLP type 5","hyperchylomicronemia late onset","hyperlipemia combined fat and carbohydrate-induced","hyperlipemia mixed","hyperlipidemia type V","hyperlipoproteinemia type 5","major hyperlipidemia","mixed hyperlipemia","type V hyperlipoproteinemia"],"takeawayHtml":"","title":"hyperlipoproteinemia type V"},"schemaVersion":1}
